CN107338201B - 马链球菌兽疫亚种sxy36及在发酵生产透明质酸中的应用 - Google Patents
马链球菌兽疫亚种sxy36及在发酵生产透明质酸中的应用 Download PDFInfo
- Publication number
- CN107338201B CN107338201B CN201710485218.4A CN201710485218A CN107338201B CN 107338201 B CN107338201 B CN 107338201B CN 201710485218 A CN201710485218 A CN 201710485218A CN 107338201 B CN107338201 B CN 107338201B
- Authority
- CN
- China
- Prior art keywords
- fermentation
- sxy36
- hyaluronic acid
- molecular weight
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 136
- 230000004151 fermentation Effects 0.000 title claims abstract description 136
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 133
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 133
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 133
- 241000194048 Streptococcus equi Species 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title abstract description 16
- 239000001963 growth medium Substances 0.000 claims description 49
- 239000007788 liquid Substances 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 26
- 239000002244 precipitate Substances 0.000 claims description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 18
- 238000012258 culturing Methods 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 238000011218 seed culture Methods 0.000 claims description 12
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000001888 Peptone Substances 0.000 claims description 9
- 108010080698 Peptones Proteins 0.000 claims description 9
- 241001052560 Thallis Species 0.000 claims description 9
- 235000015278 beef Nutrition 0.000 claims description 9
- 229940041514 candida albicans extract Drugs 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000019319 peptone Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 239000012138 yeast extract Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 229920001817 Agar Polymers 0.000 claims description 7
- 239000008272 agar Substances 0.000 claims description 7
- 238000011081 inoculation Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 230000010355 oscillation Effects 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 238000009423 ventilation Methods 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 3
- OCXRVDQYXZSPBP-UHFFFAOYSA-N 2-(16-chlorohexadecyl)pyridine Chemical compound ClCCCCCCCCCCCCCCCCC1=CC=CC=N1 OCXRVDQYXZSPBP-UHFFFAOYSA-N 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 239000007836 KH2PO4 Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 238000012262 fermentative production Methods 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 abstract description 41
- 238000000034 method Methods 0.000 abstract description 39
- 238000002703 mutagenesis Methods 0.000 abstract description 18
- 231100000350 mutagenesis Toxicity 0.000 abstract description 18
- 230000005251 gamma ray Effects 0.000 abstract description 12
- 230000015556 catabolic process Effects 0.000 abstract description 9
- 238000006731 degradation reaction Methods 0.000 abstract description 9
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 230000002949 hemolytic effect Effects 0.000 abstract description 3
- 230000006641 stabilisation Effects 0.000 abstract description 2
- 238000011105 stabilization Methods 0.000 abstract description 2
- 239000000725 suspension Substances 0.000 description 14
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 10
- 229940097043 glucuronic acid Drugs 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 8
- 238000012807 shake-flask culturing Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 238000007865 diluting Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000009835 boiling Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 108010003272 Hyaluronate lyase Proteins 0.000 description 4
- 102000001974 Hyaluronidases Human genes 0.000 description 4
- 241000120569 Streptococcus equi subsp. zooepidemicus Species 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960002773 hyaluronidase Drugs 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 210000001520 comb Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 150000002016 disaccharides Chemical group 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 231100000225 lethality Toxicity 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- LMYVDPWHMJXPIY-UHFFFAOYSA-N 2-(9h-carbazol-1-yl)ethanol Chemical compound C12=CC=CC=C2NC2=C1C=CC=C2CCO LMYVDPWHMJXPIY-UHFFFAOYSA-N 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000468 autoproteolytic effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- UZIWRCBLXLKBID-UHFFFAOYSA-N dodecasodium sulfuric acid tetraborate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].OS(O)(=O)=O UZIWRCBLXLKBID-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000010907 mechanical stirring Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- OBFSQMXGZIYMMN-UHFFFAOYSA-N 3-chloro-2-hexadecylpyridine Chemical compound CCCCCCCCCCCCCCCCC1=NC=CC=C1Cl OBFSQMXGZIYMMN-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- -1 HA oligosaccharide Chemical class 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- CPQCSJYYDADLCZ-UHFFFAOYSA-N n-methylhydroxylamine Chemical compound CNO CPQCSJYYDADLCZ-UHFFFAOYSA-N 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710485218.4A CN107338201B (zh) | 2017-06-23 | 2017-06-23 | 马链球菌兽疫亚种sxy36及在发酵生产透明质酸中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710485218.4A CN107338201B (zh) | 2017-06-23 | 2017-06-23 | 马链球菌兽疫亚种sxy36及在发酵生产透明质酸中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107338201A CN107338201A (zh) | 2017-11-10 |
CN107338201B true CN107338201B (zh) | 2021-02-02 |
Family
ID=60221175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710485218.4A Active CN107338201B (zh) | 2017-06-23 | 2017-06-23 | 马链球菌兽疫亚种sxy36及在发酵生产透明质酸中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107338201B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108410926B (zh) * | 2017-12-03 | 2021-12-14 | 新疆阜丰生物科技有限公司 | 一种制备提取高分子量透明质酸的方法 |
CN108410927B (zh) * | 2017-12-09 | 2020-10-09 | 新疆阜丰生物科技有限公司 | 一种发酵法生产高分子量透明质酸的方法 |
CN107929209A (zh) * | 2017-12-23 | 2018-04-20 | 卞国民 | 一种泥鳅面膜用的精华液 |
CN109468355A (zh) * | 2018-10-16 | 2019-03-15 | 河北科技大学 | 一种提高发酵生产透明质酸分子量的方法 |
CN114191447A (zh) * | 2020-09-18 | 2022-03-18 | 华熙生物科技股份有限公司 | 透明质酸及其盐在改善肠道菌群失调中的用途及其组合物 |
CN112195210B (zh) * | 2020-10-24 | 2022-01-04 | 上海加新生物科技有限公司 | 一种透明质酸的生产方法 |
CN114438067B (zh) * | 2022-02-11 | 2023-10-20 | 中山大学·深圳 | 一种利用3d打印技术固定微生物高产透明质酸的方法 |
CN114774316B (zh) * | 2022-04-14 | 2022-11-08 | 江南大学 | 一株马链球菌兽疫亚种突变株及其应用 |
CN114806938B (zh) * | 2022-04-20 | 2023-05-09 | 齐鲁工业大学 | 一株在低糖环境下生产透明质酸的马链球菌兽疫亚种及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103173507A (zh) * | 2011-12-23 | 2013-06-26 | 宁波林叶生物科技有限公司 | 一种利用细菌发酵生产透明质酸钠的生产工艺 |
CN104662158A (zh) * | 2012-07-05 | 2015-05-27 | 阿尔特刚意大利有限公司 | 生产具有可控分子量的高纯度透明质酸钠(hana)的方法 |
CN106434444A (zh) * | 2016-09-23 | 2017-02-22 | 东辰控股集团有限公司 | 一种马链球菌兽疫亚种及其制备透明质酸的生产工艺 |
-
2017
- 2017-06-23 CN CN201710485218.4A patent/CN107338201B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103173507A (zh) * | 2011-12-23 | 2013-06-26 | 宁波林叶生物科技有限公司 | 一种利用细菌发酵生产透明质酸钠的生产工艺 |
CN104662158A (zh) * | 2012-07-05 | 2015-05-27 | 阿尔特刚意大利有限公司 | 生产具有可控分子量的高纯度透明质酸钠(hana)的方法 |
CN106434444A (zh) * | 2016-09-23 | 2017-02-22 | 东辰控股集团有限公司 | 一种马链球菌兽疫亚种及其制备透明质酸的生产工艺 |
Non-Patent Citations (3)
Title |
---|
Biosynthesis of high molecular weight hyaluronic acid by Streptococcus zooepidemicus using oxygen vector and optimum impeller tip speed;Zee-Wei Lai等;《Journal of Bioscience and Bioengineering》;20120519;第114卷(第3期);第286-291页 * |
Highly efficient production of hyaluronic acid by Streptococcus zooepidemicus R42 derived from heterologous expression of bacterial haemoglobin and mutant selection;J.F. Lu等;《Letters in Applied Microbiology》;20161231;第62卷;第316-322页 * |
透明质酸钠热稳定性的研究;董科云等;《食品与药品》;20061231;第8卷(第01A期);图3-图6 * |
Also Published As
Publication number | Publication date |
---|---|
CN107338201A (zh) | 2017-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107338201B (zh) | 马链球菌兽疫亚种sxy36及在发酵生产透明质酸中的应用 | |
WO2023016058A1 (zh) | 一株盐单胞菌及其应用 | |
CN110331178B (zh) | 一种酶切法制备小分子透明质酸的方法及所得小分子透明质酸与其应用 | |
CN109897876B (zh) | 一种制备小分子透明质酸或其盐的方法 | |
AU2011230685A1 (en) | Anti-allergic agent | |
Shi et al. | Effect of different conditions on the average degree of polymerization of bacterial cellulose produced by Gluconacetobacter intermedius BC-41 | |
CN102876748A (zh) | 酶切法制备寡聚透明质酸盐的方法及所得寡聚透明质酸盐和其应用 | |
CN109880758B (zh) | 一种植物乳杆菌诱变菌株及其诱变方法和应用 | |
CN104120158A (zh) | 一种添加透明质酸酶提高小分子透明质酸发酵产量的方法 | |
CN111978421B (zh) | 一种桑树桑黄多糖及其制备和用途 | |
CN112094752B (zh) | 一种利用出芽短梗霉发酵生产超低分子量普鲁兰多糖的方法 | |
CN106367459A (zh) | 一种制备不同分子量寡聚透明质酸的方法 | |
CN114196564B (zh) | 一株嗜盐四联球菌及其在生产抗癌胞外多糖中的应用 | |
CN105420127B (zh) | 高分子量普鲁兰多糖的高产菌株及利用该菌株生产高分子量普鲁兰多糖的方法 | |
CN114958823A (zh) | 一种利用静磁场辅助多粘类芽孢杆菌发酵生产胞外多糖的方法 | |
CN112680435B (zh) | 一种鞘氨醇胶裂解酶及酶解鞘氨醇胶的制备方法 | |
CN112724270B (zh) | 一种低分子量苜蓿多糖及其制备方法与调节肠道菌群的应用 | |
CN104651284A (zh) | 鞘氨醇单胞菌T-3及其共发酵生产生物多糖和聚β羟基丁酸的方法 | |
CN110396531A (zh) | 生物发酵降解制备灵芝活性多糖及其分析方法 | |
CN113480672B (zh) | 一种类芽孢杆菌的胞外多糖及其应用 | |
CN113430126B (zh) | 一株短梗霉及用它制备黑色素多糖的方法 | |
CN112568445B (zh) | 一种具有益生元作用的岩藻二糖及其制备方法和应用 | |
KR101087969B1 (ko) | 미생물 배양에 의한 히알우론산을 생산하는 방법 | |
CN112143681B (zh) | 一株可产阿魏酸酯酶的贝莱斯芽孢杆菌及其应用 | |
CN114349806A (zh) | 一种应用纳豆芽孢杆菌对岩藻寡糖混合物进行单糖脱除及纯化的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230602 Address after: 412000 No.1, 1st floor, building A1, Liyu Industrial Park, Huanghe North Road extension, Tianyuan District, Zhuzhou City, Hunan Province Patentee after: Zhuzhou Zhongjian New Material Co.,Ltd. Address before: 230000 floor 1, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee before: Dragon totem Technology (Hefei) Co.,Ltd. Effective date of registration: 20230602 Address after: 230000 floor 1, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee after: Dragon totem Technology (Hefei) Co.,Ltd. Address before: 310014 No. 18 Chao Wang Road, Xiacheng District, Zhejiang, Hangzhou Patentee before: JIANG University OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240105 Address after: No. 101, Building 11, Phase I Project of Zhongnan High tech Zhuzhou Intelligent Manufacturing Industrial Park, No. 329 Xinma West Road, Liyu Street, Tianyuan District, Zhuzhou City, Hunan Province, 412000 Patentee after: Zhuzhou Zhongjian Kemi Additives Co.,Ltd. Address before: 412000 No.1, 1st floor, building A1, Liyu Industrial Park, Huanghe North Road extension, Tianyuan District, Zhuzhou City, Hunan Province Patentee before: Zhuzhou Zhongjian New Material Co.,Ltd. |
|
TR01 | Transfer of patent right |